Seth Hoogasian - Thermo Fisher Senior Vice President General Counsel, Secretary
| TMO Stock | USD 577.39 2.80 0.49% |
President
Mr. Seth H. Hoogasian is Senior Vice President, General Counsel and Secretary of the Company. He was Vice President from 1996 to November 2006. since 2006.
| Age | 61 |
| Tenure | 18 years |
| Address | 168 Third Avenue, Waltham, MA, United States, 02451 |
| Phone | 781 622 1000 |
| Web | https://www.thermofisher.com |
Thermo Fisher Management Efficiency
The company has Return on Asset of 0.0472 % which means that on every $100 spent on assets, it made $0.0472 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1309 %, implying that it generated $0.1309 on every 100 dollars invested. Thermo Fisher's management efficiency ratios could be used to measure how well Thermo Fisher manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to drop to 0.09. In addition to that, Return On Capital Employed is likely to drop to 0.05. At this time, Thermo Fisher's Other Assets are very stable compared to the past year. As of the 25th of April 2024, Fixed Asset Turnover is likely to grow to 4.79, while Net Tangible Assets are likely to drop (13.7 B).Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Brian Mi | IQVIA Holdings | 58 | |
| Jonathan Seaton | Illumina | N/A | |
| Rob Kotchie | IQVIA Holdings | N/A | |
| Marcel Roche | Guardant Health | N/A | |
| Reginald Seeto | Caredx Inc | 52 | |
| Sanjay Chikarmane | Illumina | N/A | |
| Richard III | IQVIA Holdings | 61 | |
| Alexander Johnson | Caredx Inc | 50 | |
| Mark Brecher | Laboratory of | 57 | |
| James Erlinger | IQVIA Holdings | 57 | |
| Michael Lane | IDEXX Laboratories | 55 | |
| Scott Frommer | Laboratory of | N/A | |
| Sharon Underberg | IDEXX Laboratories | 63 | |
| JD MD | Laboratory of | 50 | |
| Wendy Stewart | IQVIA Holdings | N/A | |
| Lisa Uthgenannt | Laboratory of | 57 | |
| Giovani Twigge | IDEXX Laboratories | 54 | |
| Kevin Knightly | IQVIA Holdings | 63 | |
| William Klitgaard | Laboratory of | 61 | |
| Omead Ostadan | Illumina | 46 | |
| Jon Resnick | IQVIA Holdings | N/A | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0472 |
Thermo Fisher Scientific Leadership Team
Elected by the shareholders, the Thermo Fisher's board of directors comprises two types of representatives: Thermo Fisher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thermo. The board's role is to monitor Thermo Fisher's management team and ensure that shareholders' interests are well served. Thermo Fisher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thermo Fisher's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Loewald, Sr. VP and President of Analytical Instruments | ||
| Jim Manzi, Independent Chairman of the Board | ||
| Michel Lagarde, Senior Vice President and President, Pharma Services | ||
| Mark Stevenson, Executive VP and President of Life Sciences Solutions | ||
| Rafael Tejada, Vice Relations | ||
| Stephen Williamson, Chief Financial Officer, Senior Vice President | ||
| Kenneth Apicerno, Vice President Investor Relations | ||
| Tyler Jacks, Independent Director | ||
| James Mullen, Independent Director | ||
| Dion Weisler, Independent Director | ||
| Karen Nelson, Chief Officer | ||
| Debora Spar, Independent Director | ||
| Peter Hornstra, Vice President Chief Accounting Officer | ||
| Andrew Thomson, Senior Vice President and Presidentident - Specialty Diagnostics | ||
| Martiny Harris, Independent Director | ||
| Judy Lewent, Independent Director | ||
| Michael Boxer, Senior Vice President General Counsel | ||
| Ruby Chandy, Director | ||
| Joseph Holmes, Chief Accounting Officer, Vice President | ||
| Lars Sorensen, Independent Director | ||
| Peter Wilver, Chief Admin. Officer and Executive VP | ||
| C Harris, Independent Director | ||
| Elaine Ullian, Independent Director | ||
| Thomas Lynch, Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee | ||
| Alan Malus, Executive VP and President of Laboratory Products and Services | ||
| Daniel Shine, Senior Vice President and Presidentident, Analytical Instruments | ||
| William Parrett, Independent Director | ||
| Ryan Snyder, Senior Officer | ||
| Nelson Chai, Independent Director | ||
| Sperling Sperling, Independent Director | ||
| Patrick Durbin, Senior Vice President and Presidentident - Specialty Diagnostics | ||
| Syed Jafry, Senior Vice President and President Regions | ||
| Martin Harris, Independent Director | ||
| Marc Casper, CEO and President Director, Member of Strategy and Fin. Committee and Member of Science and Technology Committee | ||
| Michael Esq, Senior Counsel | ||
| Gregory Herrema, Senior Vice President | ||
| Sandy Pound, VP Officer | ||
| Scott Sperling, Independent Director | ||
| Seth Hoogasian, Senior Vice President General Counsel, Secretary | ||
| R Keith, Independent Director | ||
| Gianluca Pettiti, Senior Vice President and Presidentident - Specialty Diagnostics business |
Thermo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Thermo Fisher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0472 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 247.84 B | ||||
| Shares Outstanding | 381.71 M | ||||
| Shares Owned By Insiders | 0.17 % | ||||
| Shares Owned By Institutions | 92.20 % | ||||
| Number Of Shares Shorted | 2.58 M | ||||
| Price To Earning | 30.99 X |
Currently Active Assets on Macroaxis
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Thermo Stock analysis
When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.054 | Dividend Share 1.4 | Earnings Share 15.46 | Revenue Per Share 111.028 | Quarterly Revenue Growth (0.05) |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.